Pd Models | List of Frontiers open access articles

Mini Review

Published on 30 Nov 2023

Convergence between the dimensional PD models of ICD-11 and DSM-5: a meta-analytic approach

in Personality Disorders

Luis Hualparuca-Olivera
Tomás Caycho-Rodríguez
Julio Torales
Dayana Ramos-Campos

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1325583

6,158 views
3 citations

Correction

Published on 21 Mar 2024

Corrigendum: Convergence between the dimensional PD models of ICD-11 and DSM-5: a meta-analytic approach

in Personality Disorders

Luis Hualparuca-Olivera
Tomás Caycho-Rodríguez
Julio Torales
Dayana Ramos-Campos

Frontiers in Psychiatry

doi 10.3389/fpsyt.2024.1366574

1,553 views

Original Research

Published on 26 Nov 2014

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

in Experimental Pharmacology and Drug Discovery

Manoranjenni Chetty
Rachel H. Rose
Khaled Abduljalil
Nikunjkumar Patel
Gaohua Lu
Theresa Cain
Masoud Jamei
Amin Rostami-Hodjegan

Frontiers in Pharmacology

doi 10.3389/fphar.2014.00258

14,107 views
54 citations

Review

Published on 22 Apr 2021

Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies

in Ethnopharmacology

Cheng-Fu Su
Li Jiang
Xiao-Wen Zhang
Ashok Iyaswamy
Min Li

Frontiers in Pharmacology

doi 10.3389/fphar.2021.644219

13,938 views
67 citations

Original Research

Published on 30 Jul 2021

Calcitriol Alleviates MPP+- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Junjie Hu
Jiawei Wu
Fang Wan
Liang Kou
Sijia Yin
Yadi Sun
Yunna Li
Qiulu Zhou
Tao Wang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2021.657095

7,600 views
22 citations

Original Research

Published on 12 Nov 2025

A novel method to simultaneously obtain multiple basic parameters for discretization-independent bond-based peridynamic analysis

in Interdisciplinary Physics

Chaobin Hu
Xiaomiao Chen

Frontiers in Physics

doi 10.3389/fphy.2025.1668291

1,018 views

Review

Published on 13 Jun 2017

Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models

in Genetics of Aging

Malabika Maulik
Swarup Mitra
Abel Bult-Ito
Barbara E. Taylor
Elena M. Vayndorf

Frontiers in Genetics

doi 10.3389/fgene.2017.00077

30,784 views
95 citations

Original Research

Published on 06 Jan 2026

Ulcerative colitis model triggers gut α-Synuclein aggregation without brain involvement or neuronal loss in female rats

in Microbial Immunology

Ana María Espinosa-Oliva
María Dolores Vázquez-Carretero
Rocío Ruiz
María A. Roca-Ceballos
Pablo García-Miranda
María José Peral
Manuel Sarmiento Soto
Antonio J. Herrera
José Luis Venero
Rocío M. de Pablos

Frontiers in Immunology

doi 10.3389/fimmu.2025.1637548

912 views

Original Research

Published on 12 Jul 2023

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease

in Translational Neuroscience

Ryota Nakamura
Risa Nonaka
Genko Oyama
Takayuki Jo
Hikaru Kamo
Maierdanjiang Nuermaimaiti
Wado Akamatsu
Kei-ichi Ishikawa
Nobutaka Hattori

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1202027

10,404 views
19 citations

Review

Published on 23 Oct 2024

The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease

in Ethnopharmacology

Kaixia Yang
Zhongyue Lv
Wen Zhao
Guogang Lai
Cheng Zheng
Feiteng Qi
Cui Zhao
Kaikai Hu
Xiao Chen
Fan Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468850

9,319 views
13 citations

Brief Research Report

Published on 04 Feb 2026

TLR3 activation in astrocytes attenuates the nigrostriatal pathway degeneration in rodent models of Parkinson’s disease

in Non-Neuronal Cells

Jaeyeong Jeong
So-Yoon Won
Young Cheul Chung
Won-Ho Shin
Byung Kwan Jin
Eun S. Park

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2026.1746731

626 views

Review

Published on 03 Jul 2020

Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges

in Translational Pharmacology

Huixi Zou
Parikshit Banerjee
Sharon Shui Yee Leung
Xiaoyu Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00997

95,189 views
107 citations

Review

Published on 23 Dec 2020

Chemically Induced Models of Parkinson’s Disease: History and Perspectives for the Involvement of Ferroptosis

in Cellular Neuropathology

Shuheng Wen
Toshihiko Aki
Kana Unuma
Koichi Uemura

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2020.581191

19,336 views
52 citations

Review

Published on 13 May 2022

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal

in Parkinson’s Disease and Aging-related Movement Disorders

Ya-Kui Mou
Li-Na Guan
Xiao-Yan Yao
Jia-Hui Wang
Xiao-Yu Song
Yong-Qiang Ji
Chao Ren
Shi-Zhuang Wei

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.890512

5,906 views
15 citations

Original Research

Published on 25 Jun 2020

Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

in Neurodegeneration

Shengyan Tai
Qian Zheng
Suzhen Zhai
Ting Cai
Li Xu
Lizhu Yang
Ling Jiao
Chunlin Zhang

Frontiers in Neuroscience

doi 10.3389/fnins.2020.00612

13,856 views
45 citations

Original Research

Published on 06 Aug 2019

Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of C. elegans

in Parkinson’s Disease and Aging-related Movement Disorders

Malabika Maulik
Swarup Mitra
Ajiel Mae Basmayor
Brianna Lu
Barbara E. Taylor
Abel Bult-Ito

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2019.00207

8,301 views
22 citations

Articles

Convergence between the dimensional PD models of ICD-11 and DSM-5: a meta-analytic approach

Corrigendum: Convergence between the dimensional PD models of ICD-11 and DSM-5: a meta-analytic approach

Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies

Calcitriol Alleviates MPP+- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson’s Disease

A novel method to simultaneously obtain multiple basic parameters for discretization-independent bond-based peridynamic analysis

Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models

Ulcerative colitis model triggers gut α-Synuclein aggregation without brain involvement or neuronal loss in female rats

A defined method for differentiating human iPSCs into midbrain dopaminergic progenitors that safely restore motor deficits in Parkinson’s disease

The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease

TLR3 activation in astrocytes attenuates the nigrostriatal pathway degeneration in rodent models of Parkinson’s disease

Application of Pharmacokinetic-Pharmacodynamic Modeling in Drug Delivery: Development and Challenges

Chemically Induced Models of Parkinson’s Disease: History and Perspectives for the Involvement of Ferroptosis

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal

Alpha-Lipoic Acid Mediates Clearance of Iron Accumulation by Regulating Iron Metabolism in a Parkinson’s Disease Model Induced by 6-OHDA

Genetic Silencing of Fatty Acid Desaturases Modulates α-Synuclein Toxicity and Neuronal Loss in Parkinson-Like Models of C. elegans